Ligand validation:4IUR

CVM: CYMAL-4

CVM is a Ligand Of Interest in 4IUR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IUR_CVM_A_302	15%	52%	0.225	0.848	0.46	1.37	-	7	0	0	67%	0.6667
4IUR_CVM_B_302	8%	66%	0.276	0.816	0.42	0.89	-	1	3	0	67%	0.6667
4IUU_CVM_B_302	17%	62%	0.238	0.814	0.46	0.99	-	3	2	0	100%	1
4IUQ_CVM_B_302	15%	17%	0.274	0.836	1.23	2.33	5	20	1	0	100%	1
4IUP_CVM_B_303	12%	56%	0.185	0.778	0.91	0.81	1	1	0	0	67%	0.6667
4IUT_CVM_B_302	11%	1%	0.27	0.846	2.43	6.05	6	8	4	0	67%	0.6667
4IUV_CVM_A_302	10%	34%	0.241	0.803	0.87	1.73	1	7	2	0	67%	0.6667
2XQU_CVM_C_103	38%	88%	0.082	0.931	0.37	0.29	-	-	0	0	18%	18.18
2WIE_CVM_B_108	27%	88%	0.129	0.922	0.34	0.33	-	-	0	0	18%	18.18
2XQS_CVM_E_106	15%	92%	0.265	0.972	0.39	0.16	-	-	1	0	18%	18.18

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.